A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers

Objective: To assess the effectiveness of the Australian Medical Sheepskin in preventing sacral pressure ulcers (PUs), based on combined data from existing published trials. Design and setting: Data from two randomised controlled trials (RCTs) among Australian hospital patients and one RCT among Dut...

Full description

Bibliographic Details
Main Authors: Mistiaen, P., Jolley, D., McGowan, Sunita, Hickey, M., Spreeuwenberg, P., Francke, A.
Format: Journal Article
Published: Australasian Medical Publishing Company Pty. Ltd. 2010
Online Access:http://www.mja.com.au/public/issues/193_11_061210/mis10295_fm.html
http://hdl.handle.net/20.500.11937/9065
_version_ 1848745841348575232
author Mistiaen, P.
Jolley, D.
McGowan, Sunita
Hickey, M.
Spreeuwenberg, P.
Francke, A.
author_facet Mistiaen, P.
Jolley, D.
McGowan, Sunita
Hickey, M.
Spreeuwenberg, P.
Francke, A.
author_sort Mistiaen, P.
building Curtin Institutional Repository
collection Online Access
description Objective: To assess the effectiveness of the Australian Medical Sheepskin in preventing sacral pressure ulcers (PUs), based on combined data from existing published trials. Design and setting: Data from two randomised controlled trials (RCTs) among Australian hospital patients and one RCT among Dutch nursing home patients were pooled, comprising a total population of 1281 patients from 45 nursing wards in 11 institutions. These data were analysed in two ways: with conventional meta-analysis based on the published effect sizes; and with multilevel binary logistic regression based on the combined individual patient data. In the multilevel analysis, patient, nursing ward and institution were used as levels and we controlled for sex, age, PU risk and number of days of observation.Main outcome measure: Incidence of sacral PUs. Results: Overall, the incidence of sacral PUs was 12.2% in the control group versus 5.4% in the intervention group with an Australian Medical Sheepskin. Conventional meta-analysis showed significantly reduced odds of developing a PU while using the sheepskin (odds ratio [OR], 0.37 [95% CI, 0.17–0.77]). Multilevel analysis gave an OR of 0.35 and narrowed the confidence interval by almost 50% (95% CI, 0.23–0.55). Conclusions: These analyses of pooled data confirm that the Australian Medical Sheepskin is effective in preventing sacral PUs. Multilevel analysis of individual patient data gives a more precise effect estimate than conventional meta-analysis.
first_indexed 2025-11-14T06:23:46Z
format Journal Article
id curtin-20.500.11937-9065
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:23:46Z
publishDate 2010
publisher Australasian Medical Publishing Company Pty. Ltd.
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-90652017-01-30T11:10:22Z A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers Mistiaen, P. Jolley, D. McGowan, Sunita Hickey, M. Spreeuwenberg, P. Francke, A. Objective: To assess the effectiveness of the Australian Medical Sheepskin in preventing sacral pressure ulcers (PUs), based on combined data from existing published trials. Design and setting: Data from two randomised controlled trials (RCTs) among Australian hospital patients and one RCT among Dutch nursing home patients were pooled, comprising a total population of 1281 patients from 45 nursing wards in 11 institutions. These data were analysed in two ways: with conventional meta-analysis based on the published effect sizes; and with multilevel binary logistic regression based on the combined individual patient data. In the multilevel analysis, patient, nursing ward and institution were used as levels and we controlled for sex, age, PU risk and number of days of observation.Main outcome measure: Incidence of sacral PUs. Results: Overall, the incidence of sacral PUs was 12.2% in the control group versus 5.4% in the intervention group with an Australian Medical Sheepskin. Conventional meta-analysis showed significantly reduced odds of developing a PU while using the sheepskin (odds ratio [OR], 0.37 [95% CI, 0.17–0.77]). Multilevel analysis gave an OR of 0.35 and narrowed the confidence interval by almost 50% (95% CI, 0.23–0.55). Conclusions: These analyses of pooled data confirm that the Australian Medical Sheepskin is effective in preventing sacral PUs. Multilevel analysis of individual patient data gives a more precise effect estimate than conventional meta-analysis. 2010 Journal Article http://hdl.handle.net/20.500.11937/9065 http://www.mja.com.au/public/issues/193_11_061210/mis10295_fm.html Australasian Medical Publishing Company Pty. Ltd. fulltext
spellingShingle Mistiaen, P.
Jolley, D.
McGowan, Sunita
Hickey, M.
Spreeuwenberg, P.
Francke, A.
A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers
title A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers
title_full A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers
title_fullStr A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers
title_full_unstemmed A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers
title_short A multilevel analysis of three randomised controlled trials of the Australian Medical Sheepskin in the prevention of sacral pressure ulcers
title_sort multilevel analysis of three randomised controlled trials of the australian medical sheepskin in the prevention of sacral pressure ulcers
url http://www.mja.com.au/public/issues/193_11_061210/mis10295_fm.html
http://hdl.handle.net/20.500.11937/9065